Related Experiment Video
Updated: May 6, 2026
Design of Cecal Ligation and Puncture and Intranasal Infection Dual Model of Sepsis-Induced Immunosuppression
Published on: June 15, 2019
Invasive candidiasis as a cause of sepsis in the critically ill patient
Julie Delaloye1, Thierry Calandra1
1Infectious Diseases Service; Department of Medicine; Centre Hospitalier Universitaire Vaudois and University of Lausanne; Lausanne, Switzerland.
Abstract:
Invasive fungal infections are an increasingly frequent etiology of sepsis in critically ill patients causing substantial morbidity and mortality. Candida species are by far the predominant agent of fungal sepsis accounting for 10% to 15% of health-care associated infections, about 5% of all cases of severe sepsis and septic shock and are the fourth most common bloodstream isolates in the United States. One-third of all episodes of candidemia occur in the intensive care setting. Early diagnosis of invasive candidiasis is critical in order to initiate antifungal agents promptly. Delay in the administration of appropriate therapy increases mortality. Unfortunately, risk factors, clinical and radiological manifestations are quite unspecific and conventional culture methods are suboptimal. Non-culture based methods (such as mannan, anti-mannan, β-d-glucan, and polymerase chain reaction) have emerged but remain investigational or require additional testing in the ICU setting. Few prophylactic or pre-emptive studies have been performed in critically ill patients. They tended to be underpowered and their clinical usefulness remains to be established under most circumstances. The antifungal armamentarium has expanded considerably with the advent of lipid formulations of amphotericin B, the newest triazoles and the echinocandins. Clinical trials have shown that the triazoles and echinocandins are efficacious and well tolerated antifungal therapies. Clinical practice guidelines for the management of invasive candidiasis have been published by the European Society for Clinical Microbiology and Infectious Diseases and the Infectious Diseases Society of North America.
Insights
Invasive fungal infections, particularly candidemia, are a growing cause of sepsis in critically ill patients. Prompt diagnosis and treatment with newer antifungals are crucial for improving outcomes.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Mycology
Background:
- Invasive fungal infections (IFIs) are a significant cause of sepsis in critically ill patients, leading to high morbidity and mortality.
- Candida species are the most common fungal pathogens, responsible for 10-15% of healthcare-associated infections and 5% of severe sepsis cases.
- Candidemia, particularly in intensive care units (ICUs), necessitates early diagnosis and treatment to reduce mortality.
Purpose of the Study:
- To review the current landscape of invasive candidiasis in critically ill patients.
- To discuss diagnostic challenges and emerging non-culture based methods.
- To highlight advancements in antifungal therapies and clinical guidelines.
Main Methods:
- Review of current literature on invasive fungal infections and candidemia in critically ill populations.
- Discussion of diagnostic modalities, including conventional cultures and newer non-culture based assays.
- Analysis of available antifungal agents, including lipid formulations of amphotericin B, triazoles, and echinocandins.
Main Results:
- Invasive candidiasis is a frequent complication in ICUs, with Candida species being the predominant cause.
- Current diagnostic methods, including cultures, have limitations, and newer non-culture based tests require further validation.
- Newer antifungal agents like triazoles and echinocandins demonstrate efficacy and tolerability.
Conclusions:
- Early diagnosis and prompt administration of appropriate antifungal therapy are critical for improving survival in patients with invasive candidiasis.
- While diagnostic tools are evolving, clinical vigilance remains essential.
- Established clinical practice guidelines provide a framework for managing invasive candidiasis.
More Related Videos
Related Concept Videos
01:29Staphylococcal Skin Infections
01:26Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:29Pneumonia I: Introduction
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:25Urinary Tract Infection II: Pathophysiology